Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel preparation method for DIDNTB achieving over 97 percent purity via optimized iodination-nitration and salification. Ideal for reliable diagnostic reagent supply chains.
Patent CN1306000A reveals a novel synthesis for a key Dronedarone intermediate, offering improved purity and simplified purification for pharmaceutical supply chains.
Discover a novel six-step preparation method for Brexpiprazole intermediates featuring high selectivity, palladium recycling, and simplified operations for cost-effective pharmaceutical manufacturing.
Patent CN110003129B reveals a green catalytic reduction route for zolmitriptan intermediates, offering high purity and simplified supply chain logistics.
Patent CN108129413A reveals a novel synthesis route for benzo[d]oxazole derivatives offering significant supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Novel azeotropic dehydration method for Esomeprazole sodium ensures high purity and yield. Optimized for commercial scale-up and supply chain reliability in pharmaceutical manufacturing.
Novel Pd-catalyzed method for difluoromethoxy intermediates. High yield, scalable process reduces costs for pharmaceutical manufacturing supply chains.
Advanced catalytic route for 4-demethoxydaunomycinone intermediates offering high purity and scalable manufacturing for antitumor drug production.
Novel diethanolamine route reduces cost and impurities for gadobutrol manufacturing ensuring supply chain reliability and high purity standards for global buyers.
Novel glucose triazole maleimide synthesis via 1,3-dipolar cycloaddition. Enhances solubility and tumor inhibition. Reliable supply chain for pharma intermediates.
Patent CN105294686A details a high-purity Riociguat method avoiding hydrogenation, offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN104263802B enables high-purity S-1-tetrahydronaphthalene amines via dynamic kinetic resolution, ensuring supply chain reliability.
Novel patent CN116836095B offers high-yield synthesis for pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability with green chemistry.
Patent CN107721875A reveals water-based chromatographic purification for Iohexol ensuring high purity and reduced environmental impact for supply chains.
Patent CN112480112A reveals a metal-free route for dihydrophenanthroline synthesis offering mild conditions and high yields for pharmaceutical intermediate manufacturing.
Novel Friedel-Crafts route avoids nitration for ADC intermediates. High yield, scalable process for camptothecin derivatives and pharmaceutical manufacturing.
Novel base-promoted synthesis patent CN116987036B offers high-purity intermediates with scalable cost reduction for global pharmaceutical supply chains.
Discover novel carbapenem derivatives with enhanced beta-lactamase stability. Optimize your antibiotic supply chain with our scalable synthesis routes.
Patent CN115433721B details a carbonyl reductase mutant for BHBM synthesis, offering water-based media and superior thermal stability for cost-effective pharma manufacturing.
Patent CN1292378A reveals a novel synthesis route for broad-spectrum antifungal intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.